Scope of application of the ursodeoxycholic acid at gastroenterological pathology
Journal Title: Сучасна гастроентерологія - Year 2019, Vol 0, Issue 2
Abstract
The article presents modern concepts on the using of ursodeoxycholic acid in the clinical practice of internist. The presented review is focused on the effects of ursodeoxycholic acid, the current spectrum of it’s application in the treatment of the patients with gastroenterological pathology, in particular, gastroesophageal reflux disease, non-alcoholic fatty liver disease, autoimmune hepatobiliary processes, chronic hepatitis, intestinal dysbiosis. The literature review has covered the historical data on the release of ursodeoxycholic acid, the first studies on the results of this drug using, and listed the ursodeoxycholic acid effects and scope of application. The literature review presents data from the global studies of the ursodeoxychloric acid effects on patients with the above listed nosology. The efficacy of its preparation has been proved in terms of reduction of the clinical manifestations of intrahepatic cholestasis in pregnant women without side effects. The presented data showed the survival prolongation in patients with primary biliary cholangitis against the background of ursodeoxychloric acid administration. It has been emphasized that long-term use of ursodeoxycholic acid at viral hepatitis, along with etiotropic therapy, allowed to eliminate the clinical manifestations and to avoid the development of complications. It was demonstrated that ursodeoxycholic acid has protective properties against the damaging effect of bile acids on the esophagus walls at gastroesophageal reflux disease. The data have been presented on the UCDA positive effects on the lipid spectrum in patients with non-alcoholic fatty liver disease. The data illustrating the significant positive differences in the composition and function of the microbiome after prolonged use of ursodeoxycholic acid have been outlined.
Authors and Affiliations
L. V. Zhuravlyova, O. V. Ogneva
Keywords
Related Articles
- EP ID EP575139
- DOI 10.30978/MG-2019-2-66
- Views 121
- Downloads 0
United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis
-
First experience of the study of prevalence of the Helicobacter pylori-negative peptic ulcer in Lviv Region
The prevalence of Helicobacter pylori-negative peptic ulcers of the stomach and duodenum in Ukraine has not been studied yet. The lack of accounting for such patients, lack of knowledge of risk factors for the developmen...
V Maastricht consensus: the personified approach to the eradication therapy with account of the regional peculiarities of Ukraine
The key provisions of the V Maastricht Consensus on the diagnosis and treatment of Helicobacter pylori infection have been considered. The analysis has been performed for the main results of eradication therapy for the l...
Irritable bowel syndrome at young age: Salofalk treatment efficacy
Objective — to analyze the effect of granules of mesalazine on the course of IBS in adolescents and young patients. Materials and methods. We observed 58 children in late adolescence from 15 to 18 years old and 120 youn...
Hyperplastic polyps, serrated adenomas — relevance of the topic, classification, morphological signs and risks of colorectal carcinoma
The paper present the proof for risks of the rectal carcinoma developing from the serrated polyps, adenomas. The histological structure of these tumors is typical, therefore, they should be morphologically verified. The...